MRL-37

From WikiMD's Medical Encyclopedia

Revision as of 03:21, 2 December 2024 by Prab (talk | contribs) (CSV import)
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)

MRL-37

MRL-37 is a synthetic peptide with potential antimicrobial properties. It is part of a class of peptides known as antimicrobial peptides (AMPs), which are being studied for their ability to combat bacterial infections, particularly those caused by antibiotic-resistant strains.

Structure and Composition[edit]

MRL-37 is a cationic peptide, meaning it carries a positive charge. This characteristic is crucial for its interaction with the negatively charged components of bacterial cell membranes. The peptide is composed of 37 amino acids, which are arranged in a sequence that allows it to adopt an amphipathic structure. This structure is essential for its ability to insert into and disrupt bacterial membranes.

Mechanism of Action[edit]

The primary mechanism by which MRL-37 exerts its antimicrobial effects is through membrane disruption. Upon contact with bacterial cells, MRL-37 binds to the membrane and integrates into the lipid bilayer. This integration leads to the formation of pores or channels, resulting in the leakage of cellular contents and ultimately cell death. This mode of action is distinct from that of traditional antibiotics, which often target specific bacterial enzymes or pathways.

Potential Applications[edit]

MRL-37 is being investigated for its potential use in treating infections caused by multi-drug resistant bacteria. Its ability to disrupt bacterial membranes makes it a promising candidate for use against a broad spectrum of bacteria, including Gram-positive and Gram-negative strains. Additionally, MRL-37 may have applications in the development of topical treatments for skin infections and as a preservative in various products due to its antimicrobial properties.

Research and Development[edit]

Research on MRL-37 is ongoing, with studies focusing on optimizing its stability, efficacy, and safety for potential therapeutic use. Challenges in the development of MRL-37 include ensuring its selective toxicity towards bacterial cells over human cells and improving its stability in physiological conditions.

Also see[edit]

Template:Antimicrobial peptides Template:Peptide research

Navigation: Wellness - Encyclopedia - Health topics - Disease Index‏‎ - Drugs - World Directory - Gray's Anatomy - Keto diet - Recipes

Ad. Transform your health with W8MD Weight Loss, Sleep & MedSpa

W8MD's happy loser(weight)

Tired of being overweight?

Special offer:

Budget GLP-1 weight loss medications

  • Semaglutide starting from $29.99/week and up with insurance for visit of $59.99 and up per week self pay.
  • Tirzepatide starting from $45.00/week and up (dose dependent) or $69.99/week and up self pay

✔ Same-week appointments, evenings & weekends

Learn more:

Advertise on WikiMD


WikiMD Medical Encyclopedia

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.